ArticleDiabetes, obesity & metabolism2025
Incidence of chronic kidney disease among adults with prediabetes in the CURE-CKD registry, 2013-2020.
Abstract readLetter
In one paragraph
Article in Diabetes, obesity & metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Gaining Community Trust Enables Research Designed to Reduce the National Burden of Chronic Kidney Disease.Journal of immigrant and minority health · 2026Review
- Association of Tirzepatide With Kidney Parameters in Participants With Obesity and Prediabetes From SURMOUNT-1 Over 176 Weeks.Diabetes, obesity & metabolism · 2026Article
- Clinical and economic burden of chronic kidney disease in Medicare Fee-for-Service beneficiaries with and without comorbid type 2 diabetes and heart failure: A retrospective cohort study.Journal of managed care & specialty pharmacy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Radica Z AlicicProvidence Medical Research Center, Providence Inland Northwest Health, Spokane, Washington, USA.ORCID https://orcid.org/0000-0002-5437-5700
Obidiugwu K DuruDivision of General Internal Medicine & Health Services Research, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
Cami R JonesProvidence Medical Research Center, Providence Inland Northwest Health, Spokane, Washington, USA.
Lindsey M KornowskeProvidence Medical Research Center, Providence Inland Northwest Health, Spokane, Washington, USA.
Kenn B DarathaProvidence Medical Research Center, Providence Inland Northwest Health, Spokane, Washington, USA.
Christina L ReynoldsProvidence Medical Research Center, Providence Inland Northwest Health, Spokane, Washington, USA.
Meda E PavkovDivision of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Alain K KoyamaDivision of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Fang XuDivision of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Susanne B NicholasDivision of General Internal Medicine & Health Services Research, David Geffen School of Medicine, University of California, Los Angeles, California, USA.ORCID https://orcid.org/0000-0003-3535-9120
Joshua J NeumillerProvidence Medical Research Center, Providence Inland Northwest Health, Spokane, Washington, USA.
Keith C NorrisDivision of General Internal Medicine & Health Services Research, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
Kelly A HennesseyDepartment of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Katherine R TuttleProvidence Medical Research Center, Providence Inland Northwest Health, Spokane, Washington, USA.ORCID https://orcid.org/0000-0002-2235-0103
Funding
OTA-21-015A Post-Acute Sequelae of SARS-CoV-2 Infection Initiative: NYU Langone Health Clinical Science Core, Data Resource Core, and PASC Biorepository CoreOT2HL161847 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI GROSS, RACHEL SHARON, HORWITZ, LEORA · 2021 to 2025
$651.0MCOVID-19 Supplement - Center for Innovative TRIals in ChilDrEN and AdulTs (TRIDENT)U24TR001608 · NCATS · DUKE UNIVERSITY · PI BENJAMIN, DANIEL K., BERNARD, GORDON RAPHAEL · 2016 to 2022
$177.0MAIM-AHEAD Coordinating Center - All Four CoresOT2OD032581 · OD · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI Paul Avillach, Bettina M. Beech · 2021 to 2026
$168.7MUCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1MTransform Dissemination and Implementation Science in CTSA ProgramsUL1TR002319 · NCATS · UNIVERSITY OF WASHINGTON · PI John K. Amory · 2017 to 2026
$100.0MConProject-002U2CDK114886 · NIDDK · UNIVERSITY OF WASHINGTON · PI HIMMELFARB, JONATHAN · 2017 to 2021
$21.0MTraining Program in Clinical & Translationa Research in Human Glomerular DiseaseU54DK083912 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KRETZLER, MATTHIAS · 2009 to 2023
$20.3MThe Center for Health Improvement of Minority ElderlyP30AG021684 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CATHERINE A SARKISIAN · 2002 to 2026
$19.7MUCLA-UCI Center for Eliminating Cardio-Metabolic Disparities in Multi-Ethnic Populations (UC END-DISPARITIES)P50MD017366 · NIMHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BODEN-ALBALA, BERNADETTE MARIE · 2021 to 2025
$17.3MCureGN-Penn PCCU01DK100846 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI LAWRENCE B. HOLZMAN · 2019 to 2026
$8.3MObesity Health Disparities Research PRIDE Program (OHD PRIDE)R25HL126145 · NHLBI · UNIVERSITY OF MISSISSIPPI MED CTR · PI BEECH, BETTINA M., BRUCE, MARINO A · 2014 to 2025
$3.9MImproving Influenza Vaccination Delivery Across a Health System by the Electronic Health Records Patient PortalR01AI135029 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SZILAGYI, PETER G · 2018 to 2022
$3.7MNCATS NIH HHS UL1 TR001881NCATS NIH HHS UL1 TR002319NCCDPHP CDC HHS U18 DP006535NHLBI NIH HHS OT2 HL161847NHLBI NIH HHS R25 HL126145NHLBI NIH HHS R25 HL161609NIA NIH HHS P30 AG021684NIDDK NIH HHS R01 DK124503NIDDK NIH HHS R01 DK127733NIDDK NIH HHS R18 DK122372NIDDK NIH HHS U01 DK100846NIDDK NIH HHS U2C DK114886NIDDK NIH HHS U2C DK129496NIDDK NIH HHS U54 DK083912NIH HHS 75D301-21-P-12254NIH HHS 75D301-23-C-18264NIH HHS OT2HL161847NIH HHS OT2 OD032581NIH HHS OT2OD032581NIH HHS P30AG021684NIH HHS P50MD017366NIH HHS R01AI135029NIH HHS R01DK124503NIH HHS R01DK127733NIH HHS R01MD014712NIH HHS R18DK122372NIH HHS R25HL161609NIH HHS RF00250-2022-0038NIH HHS U01DK100846NIH HHS U18DP006535NIH HHS U24TR001608NIH HHS U2CDK114886NIH HHS U2CDK129496NIH HHS U54DK083912NIH HHS UL1TR001881NIH HHS UL1TR002319NIH HHS UM1AI109568NIMHD NIH HHS P50 MD017366NIMHD NIH HHS R01 MD014712
Abstract
PubMed holds no abstract for this paper.
Indexed as
chronic kidney diseaseobservational studyprediabetes
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.